Alex Sparreboom

20PUBLICATIONS
88CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Electronic and magnetic properties of condensed matter; superconductivityInjury preventionPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jul 29, 2026
Insights and perspectives into the etiology of TKI-induced cardiotoxicity.

|Mar 02, 2026
Mechanisms Underlying Cedazuridine-Mediated Enhancement of Oral Decitabine Bioavailability.

Nadeen Anabtawi, Thomas Drabison, Alexander F Ham

|Jan 27, 2026
Pacific Blue Derivatives of Paclitaxel as Fluorescent Probes of OATP1B-Type Transporters.

Mahesh R Nepal, Yue Xu, Yan Jin

|Dec 30, 2025
OATP2B1 Deficiency Ameliorates Irinotecan-Induced Gastrointestinal Toxicity.

Hanieh Taheri, Peter de Bruijn, Yang Li

|Aug 22, 2025
Drug-Drug Interaction Liabilities with BTK Inhibitor TL-895.

Jack C Stromatt, Eman A Ahmed, Thomas Drabison

|Apr 26, 2025
Determination and Disposition of the Aromatase Inhibitor Exemestane in CYP3A-Deficient Mice.

Hanieh Taheri, Eman Ahmed, Peng Hu

Pageof 4

Frequent Collaborators

10 joint publications

Shuiying Hu

8 joint publications

Eric D Eisenmann

7 joint publications

Sharyn D Baker

5 joint publications

Kevin M Huang